Association between BNP levels and new-onset atrial fibrillation. A propensity score approach

Karabag Y., Rencuzogullari I., Cagdas M., Karakoyun S., Yesin M., Uluganyan M., ...Daha Fazla

HERZ, cilt.43, sa.6, ss.548-554, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 43 Sayı: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s00059-017-4598-6
  • Dergi Adı: HERZ
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.548-554
  • Anahtar Kelimeler: B-type natriuretic peptide, Atrial fibrillation, ST-segment elevationmyocardial infarction, Prognostic factors, Percutaneous coronary intervention, ACUTE MYOCARDIAL-INFARCTION, BRAIN NATRIURETIC PEPTIDE, ST-SEGMENT ELEVATION, PERCUTANEOUS CORONARY INTERVENTION, PROGNOSTIC-SIGNIFICANCE, EUROPEAN-SOCIETY, GUIDELINES, ECHOCARDIOGRAPHY, REPERFUSION, DYSFUNCTION
  • Atatürk Üniversitesi Adresli: Evet

Özet

New-onset atrial fibrillation (NOAF), a common complication of acute ST-segment elevation myocardial infarction (STEMI), is associated with a poor prognosis. Several clinical and laboratory parameters are reported to be associated with NOAF in patients with STEMI. The aim of the present study was to evaluate the predictive value of plasma BaEurotype natriuretic peptide (BNP) levels for NOAF development and long-term prognosis in STEMI patients undergoing primary percutaneous coronary intervention (pPCI).